Heidi Albert

Summary

Affiliation: Foundation for Innovative New Diagnostics
Country: Switzerland

Publications

  1. pmc Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy
    Heidi Albert
    FIND, Foundation for Innovative New Diagnostics, Kampala, Uganda
    BMC Infect Dis 11:125. 2011
  2. ncbi request reprint Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis
    H Albert
    Biotec Laboratories Ltd, Somerset Hospital, Greenpoint, Cape Town, South Africa
    J Appl Microbiol 103:892-9. 2007
  3. pmc Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda
    Heidi Albert
    Tuberculosis Research Laboratory, Foundation for Innovative New Diagnostics, Kampala, Uganda
    PLoS ONE 5:e15206. 2010
  4. pmc Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
    Heidi Albert
    Foundation for Innovative New Diagnostics, Kampala, Uganda
    BMC Infect Dis 10:41. 2010
  5. ncbi request reprint Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis
    Richard Mole
    Biotec Laboratories Ltd, Somerset Hospital, Greenpoint, Cape Town, South Africa
    J Med Microbiol 56:1334-9. 2007
  6. pmc Clinical Predictors and Accuracy of Empiric Tuberculosis Treatment among Sputum Smear-Negative HIV-Infected Adult TB Suspects in Uganda
    Lydia Nakiyingi
    Infectious Diseases Institute, Makerere College of Health Sciences, Kampala, Uganda School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    PLoS ONE 8:e74023. 2013
  7. pmc Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
    Catharina C Boehme
    Foundation for Innovative New Diagnostics, Geneva, Switzerland
    Lancet 377:1495-505. 2011
  8. ncbi request reprint Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape
    H Albert
    Biotec Laboratories Ltd, Somerset Hospital, Cape Town, South Africa
    S Afr Med J 97:858-63. 2007
  9. pmc Operational Implementation of LED Fluorescence Microscopy in Screening Tuberculosis Suspects in an Urban HIV Clinic in Uganda
    Heidi Albert
    Foundation for Innovative New Diagnostics FIND, Kampala, Uganda
    PLoS ONE 8:e72556. 2013
  10. ncbi request reprint Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test
    H Albert
    Biotec Laboratories Ltd, Johannesburg, South Africa
    Int J Tuberc Lung Dis 6:523-8. 2002

Collaborators

Detail Information

Publications14

  1. pmc Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy
    Heidi Albert
    FIND, Foundation for Innovative New Diagnostics, Kampala, Uganda
    BMC Infect Dis 11:125. 2011
    ..Simpler concentration methods that could be applied in peripheral laboratories are urgently needed...
  2. ncbi request reprint Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis
    H Albert
    Biotec Laboratories Ltd, Somerset Hospital, Greenpoint, Cape Town, South Africa
    J Appl Microbiol 103:892-9. 2007
    ..To develop and evaluate an antimicrobial supplement for use with phage-based tests for rapid detection of drug resistance of tuberculosis (TB)...
  3. pmc Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda
    Heidi Albert
    Tuberculosis Research Laboratory, Foundation for Innovative New Diagnostics, Kampala, Uganda
    PLoS ONE 5:e15206. 2010
    ....
  4. pmc Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
    Heidi Albert
    Foundation for Innovative New Diagnostics, Kampala, Uganda
    BMC Infect Dis 10:41. 2010
    ..Line probe assays (LPAs) have been recently approved for use in low income settings and can be used to screen smear-positive sputum specimens for resistance to rifampicin and isoniazid in 1-2 days...
  5. ncbi request reprint Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis
    Richard Mole
    Biotec Laboratories Ltd, Somerset Hospital, Greenpoint, Cape Town, South Africa
    J Med Microbiol 56:1334-9. 2007
    ..Thus, the use of NOA improves the robustness of the test, facilitating its wider implementation...
  6. pmc Clinical Predictors and Accuracy of Empiric Tuberculosis Treatment among Sputum Smear-Negative HIV-Infected Adult TB Suspects in Uganda
    Lydia Nakiyingi
    Infectious Diseases Institute, Makerere College of Health Sciences, Kampala, Uganda School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    PLoS ONE 8:e74023. 2013
    ..We sought to determine the clinical predictors and accuracy of empiric TB treatment initiation in HIV-infected sputum smear-negative TB suspects using sputum culture as a reference standard...
  7. pmc Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
    Catharina C Boehme
    Foundation for Innovative New Diagnostics, Geneva, Switzerland
    Lancet 377:1495-505. 2011
    ..We aimed to assess operational feasibility, accuracy, and effectiveness of implementation in such settings...
  8. ncbi request reprint Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape
    H Albert
    Biotec Laboratories Ltd, Somerset Hospital, Cape Town, South Africa
    S Afr Med J 97:858-63. 2007
    ..The ability of rifampicin resistance to predict MDR-TB was also determined...
  9. pmc Operational Implementation of LED Fluorescence Microscopy in Screening Tuberculosis Suspects in an Urban HIV Clinic in Uganda
    Heidi Albert
    Foundation for Innovative New Diagnostics FIND, Kampala, Uganda
    PLoS ONE 8:e72556. 2013
    ..We sought to compare the operational performance of three LED FM methods compared to light microscopy in a cohort of HIV-positive tuberculosis (TB) suspects at an urban clinic in a high TB burden country...
  10. ncbi request reprint Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test
    H Albert
    Biotec Laboratories Ltd, Johannesburg, South Africa
    Int J Tuberc Lung Dis 6:523-8. 2002
    ..A Mycobacteriology Reference Laboratory in Johannesburg, South Africa...
  11. ncbi request reprint Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum
    H Albert
    Biotec Laboratories Ltd, c o National Health Laboratory Service, Cape Town, Western Cape, South Africa
    Int J Tuberc Lung Dis 8:1114-9. 2004
    ..Cape Town, South Africa...
  12. ncbi request reprint Economic analysis of the diagnosis of smear-negative pulmonary tuberculosis in South Africa: incorporation of a new rapid test, FASTPlaqueTB, into the diagnostic algorithm
    H Albert
    Biotec Laboratories Ltd, c o National Health Laboratory Service, Cape Town, Western Cape, South Africa
    Int J Tuberc Lung Dis 8:240-7. 2004
    ....
  13. ncbi request reprint Performance of FASTPlaqueTB and a modified protocol in a high HIV prevalence community in South Africa
    Andre P Trollip
    Biotec Laboratories South Africa Ltd, Cape Town, South Africa
    Int J Tuberc Lung Dis 13:791-3. 2009
    ..Before the FASTPlaqueTB can be considered as a viable replacement for smear microscopy and culture for the identification of tuberculosis, further work is required to resolve the performance issues identified in this study...
  14. pmc Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence
    O J Strauss
    DST NRF Centre of Excellence for Biomedical Tuberculosis Research MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
    J Clin Microbiol 46:1514-6. 2008
    ..Transmission was linked to human immunodeficiency virus coinfection (P = 0.029), raising concern for the spread of drug resistance in vulnerable populations...